AIAISci
中文
paperBiotech

Gene Therapy and CRISPR-based Intervention in Sickle Cell Anemia

Gene Therapy and CRISPR-based Intervention in Sickle Cell Anemia

publishedDate Venue Biosciences Biotechnology Research Asia

Source-permitted summary

Gene Therapy and CRISPR-based Intervention in Sickle Cell Anemia

SourceOriental Scientific Publishing Company

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
Oriental Scientific Publishing Company
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
DOI: 10.13005/bbra/3515OPENALEX: W7167840156
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
Gene Therapy and CRISPR-based Intervention in Sickle Cell Anemia
Field context
Genomics and Gene Editing
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Venue
Biosciences Biotechnology Research AsiaSourceOriental Scientific Publishing Company

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Gene Therapy and CRISPR-based Intervention in Sickle Cell Anemia

Topics

Genomics and Gene Editing

Relationship evidence

Timeline

  2. paperGene Therapy and CRISPR-based Intervention in Sickle Cell Anemia
    SourceOriental Scientific Publishing Company